A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
enhance medical device communications and ensure de-
vice cleanliness. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Disclosure; and En-
4
couragement of Verification, Innovation, Cleaning, and 
5
Efficiency Act of 2021’’ or the ‘‘DEVICE Act of 2021’’. 
6
23:49 Feb 25, 2021
H887
2 
•HR 887 IH
SEC. 2. REPORTING REQUIREMENT FOR DESIGN AND RE-
1
PROCESSING INSTRUCTION CHANGES. 
2
(a) ADULTERATION.—Section 501 of the Federal 
3
Food, Drug, and Cosmetic Act (21 U.S.C. 351) is amend-
4
ed by inserting after paragraph (j) the following: 
5
‘‘(k) If it is a device with respect to which the manu-
6
facturer is in violation of the reporting requirement in sec-
7
tion 510(r) (relating to design and reprocessing 
8
changes).’’. 
9
(b) REQUIREMENT.—Section 510 of the Federal 
10
Food, Drug, and Cosmetic Act (21 U.S.C. 360) is amend-
11
ed by adding at the end the following: 
12
‘‘(r) REPORTING REQUIREMENT FOR DEVICE DE-
13
SIGN CHANGES.—Before making a change to the design 
14
of a device, or the reprocessing instructions of a device, 
15
that is marketed in interstate commerce, the manufacturer 
16
of the device shall give written notice of the change to 
17
the Food and Drug Administration.’’. 
18
SEC. 3. REPORTING REQUIREMENT FOR CERTAIN COMMU-
19
NICATIONS TO FOREIGN HEALTH CARE PRO-
20
VIDERS. 
21
(a) ADULTERATION.—Section 501 of the Federal 
22
Food, Drug, and Cosmetic Act (21 U.S.C. 351), as 
23
amended by section 2 of this Act, is further amended by 
24
inserting after paragraph (k) the following: 
25
23:49 Feb 25, 2021
H887
3 
•HR 887 IH
‘‘(l) If it is a device with respect to which the manu-
1
facturer is in violation of the reporting requirement in sec-
2
tion 510(s) (relating to communications to foreign health 
3
care providers).’’. 
4
(b) REQUIREMENT.—Section 510 of the Federal 
5
Food, Drug, and Cosmetic Act (21 U.S.C. 360), as 
6
amended by section 2 of this Act, is further amended by 
7
adding at the end the following: 
8
‘‘(s) REPORTING REQUIREMENT FOR CERTAIN COM-
9
MUNICATIONS TO FOREIGN HEALTH CARE PROVIDERS.— 
10
‘‘(1) REQUIREMENT.—The manufacturer of a 
11
device that is marketed in interstate commerce shall 
12
give written notice to the Food and Drug Adminis-
13
tration of any communication described in para-
14
graph (2) not more than 5 calendar days after mak-
15
ing such communication. 
16
‘‘(2) COMMUNICATION DESCRIBED.—A commu-
17
nication is described in this paragraph if the com-
18
munication— 
19
‘‘(A) is made by the manufacturer of the 
20
device or an affiliate of the manufacturer; 
21
‘‘(B) relates to a change to the design of 
22
the device, a change to the recommended re-
23
processing protocols, if any, for the device, or a 
24
safety concern about the device; and 
25
23:49 Feb 25, 2021
H887
4 
•HR 887 IH
‘‘(C) is widely disseminated (including on a 
1
voluntary basis) to health care providers in a 
2
foreign country. 
3
‘‘(3) AFFILIATE.—In this subsection, the term 
4
‘affiliate’ means a business entity that has a rela-
5
tionship with a second business entity if, directly or 
6
indirectly— 
7
‘‘(A) one business entity controls, or has 
8
the power to control, the other business entity; 
9
or 
10
‘‘(B) a third party controls, or has the 
11
power to control, both of the business entities.’’. 
12
SEC. 4. RAPID ASSESSMENT TESTS INTENDED TO ENSURE 
13
PROPER REPROCESSING. 
14
(a) INCLUSION
IN DEVICE DEFINITION.—Section 
15
201 of the Federal Food, Drug, and Cosmetic Act (21 
16
U.S.C. 321) is amended— 
17
(1) in paragraph (h)— 
18
(A) in subparagraph (2), by striking ‘‘or’’ 
19
at the end; 
20
(B) in subparagraph (3), by striking ‘‘and’’ 
21
at the end and inserting ‘‘or’’; and 
22
(C) by inserting after subparagraph (3) 
23
the following: 
24
23:49 Feb 25, 2021
H887
5 
•HR 887 IH
‘‘(4) a rapid assessment test intended to ensure 
1
the proper reprocessing of a reusable device (as de-
2
fined in paragraph (ss)), and’’; and 
3
(2) by adding at the end the following: 
4
‘‘(ss) The term ‘reusable device’ means a device 
5
that— 
6
‘‘(1) is intended to be used more than one time; 
7
and 
8
‘‘(2) must be sanitized (whether through clean-
9
ing, disinfection, or sterilization) to ensure that the 
10
device is safe and effective for such intended use.’’. 
11
(b) INSTRUCTIONS
FOR
USE
AND
VALIDATION 
12
DATA.—Section 510 of the Federal Food, Drug, and Cos-
13
metic Act (21 U.S.C. 360), as amended by sections 2 and 
14
3 of this Act, is further amended by adding at the end 
15
the following: 
16
‘‘(t) INSTRUCTIONS
FOR
USE
AND
VALIDATION 
17
DATA.— 
18
‘‘(1) INITIAL LIST.—Not later than 1 year after 
19
the date of enactment of this subsection, the Sec-
20
retary shall by regulation develop and publish a list 
21
of types of rapid assessment tests described in sec-
22
tion 201(h)(4) for which reports under subsection 
23
(k) must include— 
24
23:49 Feb 25, 2021
H887
6 
•HR 887 IH
‘‘(A) instructions for use that have been 
1
validated in a manner specified by the Sec-
2
retary; and 
3
‘‘(B) validation data, of the types specified 
4
by the Secretary. 
5
‘‘(2) UPDATES.—The Secretary shall by regula-
6
tion periodically update the list required by para-
7
graph (1). 
8
‘‘(3) ENFORCEMENT.—Beginning on the date 
9
of publication of the initial list under paragraph (1), 
10
the Secretary shall not accept any notification under 
11
subsection (k) for clearance of a type of rapid as-
12
sessment test that is included on such list unless 
13
such notification includes instructions for use and 
14
validation data in accordance with paragraph (1).’’. 
15
Æ 
23:49 Feb 25, 2021
H887
